Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 4;12(2):352.
doi: 10.3390/cancers12020352.

A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer

Affiliations
Review

A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer

Li Liu et al. Cancers (Basel). .

Abstract

The difficulty of early diagnosis and the development of drug resistance are two major barriers to the successful treatment of cancer. Autophagy plays a crucial role in several cellular functions, and its dysregulation is associated with both tumorigenesis and drug resistance. Unc-51-like kinase 1 (ULK1) is a serine/threonine kinase that participates in the initiation of autophagy. Many studies have indicated that compounds that directly or indirectly _target ULK1 could be used for tumor therapy. However, reports of the therapeutic effects of these compounds have come to conflicting conclusions. In this work, we reviewed recent studies related to the effects of ULK1 on the regulation of autophagy and the development of drug resistance in cancers, with the aim of clarifying the mechanistic underpinnings of this therapeutic _target.

Keywords: ULK1; autophagy; cancer; drug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure and biological function of ULK1. The domain of ULK1 contains three units including a kinase domain (KD), proline/serine-rich (PS) region, and C-terminal domain (CTD). AMPK and mTORC1 are upstream kinases that regulate ULK1. ATF4 is an activating transcription factor that directly regulates transcription of ULK1.
Figure 2
Figure 2
Summary of the relationships between ULK1, autophagy, and cancer.
Figure 3
Figure 3
A summary of how ULK1 is involved in the development of drug resistance in cancer.

Similar articles

Cited by

References

    1. Chow L.Q.M. Head and Neck Cancer. N. Engl. J. Med. 2020;382:60–72. doi: 10.1056/NEJMra1715715. - DOI - PubMed
    1. Zhou Y., Shen Y., Chen C., Sui X., Yang J., Wang L., Zhou J. The crosstalk between autophagy and ferroptosis: what can we learn to _target drug resistance in cancer? Cancer Biol. Med. 2019;16:630–646. doi: 10.20892/j.issn.2095-3941.2019.0158. - DOI - PMC - PubMed
    1. Vasan N., Baselga J., Hyman D.M. A view on drug resistance in cancer. Nature. 2019;575:299–309. doi: 10.1038/s41586-019-1730-1. - DOI - PMC - PubMed
    1. Chen D., Wang C.Y. _targeting cancer stem cells in squamous cell carcinoma. Precis. Clin. Med. 2019;2:152–165. doi: 10.1093/pcmedi/pbz016. - DOI - PMC - PubMed
    1. Ou J., Peng Y., Yang W., Zhang Y., Hao J., Li F., Chen Y., Zhao Y., Xie X., Wu S., et al. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Nat. Commun. 2019;10:1–14. doi: 10.1038/s41467-019-08902-x. - DOI - PMC - PubMed

LinkOut - more resources

  NODES
twitter 2